Bitterman Jumps From Polaris to Atlas to Build More Bio Startups

Xconomy Boston — 

Kevin Bitterman has left Polaris Partners, where he spent more than a decade helping build biotech companies, to become a partner at another Boston-area life sciences venture firm, Atlas Venture. Bitterman was the founding CEO of Editas Medicine (NASDAQ: EDIT), Visterra, and Morphic Therapeutic, helped co-found Genocea Biosciences (NASDAQ: GNCA), and is also the chairman of the New England Venture Capital Association. Here’s more on the hire from Atlas partner Bruce Booth’s blog.